Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASB Treat Study
NL-OMON36603Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2011
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asymptomatic bacteriuria (ASB) comparing Nitrofurantoin with Placebo (2 arms). Primary endpoints: Pyelonephritis and Preterm delivery before 34 weeks of gestation. Started Nov 2011; status: active, not recruiting.
02
Drugs
nitrofurantoin
03
Conditions
asymptomatic bacteriuria (ASB)
Beyond the preview
Go deeper on NL-OMON36603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36603.